WO2003052064A3 - Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media - Google Patents
Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media Download PDFInfo
- Publication number
- WO2003052064A3 WO2003052064A3 PCT/US2002/039496 US0239496W WO03052064A3 WO 2003052064 A3 WO2003052064 A3 WO 2003052064A3 US 0239496 W US0239496 W US 0239496W WO 03052064 A3 WO03052064 A3 WO 03052064A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell lines
- chemically defined
- defined media
- myeloma cell
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
- C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002362130A AU2002362130A1 (en) | 2001-12-14 | 2002-12-11 | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
CA002470026A CA2470026A1 (en) | 2001-12-14 | 2002-12-11 | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
EP02797264A EP1490481A4 (en) | 2001-12-14 | 2002-12-11 | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
JP2003552931A JP2005512538A (en) | 2001-12-14 | 2002-12-11 | A clonal myeloma cell line useful for producing proteins in serum-free medium |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33942901P | 2001-12-14 | 2001-12-14 | |
US60/339,429 | 2001-12-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003052064A2 WO2003052064A2 (en) | 2003-06-26 |
WO2003052064A3 true WO2003052064A3 (en) | 2004-10-28 |
Family
ID=23328968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/039496 WO2003052064A2 (en) | 2001-12-14 | 2002-12-11 | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1490481A4 (en) |
JP (1) | JP2005512538A (en) |
AU (1) | AU2002362130A1 (en) |
CA (1) | CA2470026A1 (en) |
WO (1) | WO2003052064A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678570B2 (en) | 2004-03-01 | 2010-03-16 | Kitakyushu Foundation For The Advancement Of Industry, Science And Technology | Human cell strains for protein production, provided by selecting strains with high intracellular protein and mutating with carcinogens |
US7531327B2 (en) * | 2004-07-23 | 2009-05-12 | Immunomedics, Inc. | Methods and compositions for increasing longevity and protein yield from a cell culture |
JP5378682B2 (en) * | 2004-07-23 | 2013-12-25 | イミューノメディクス、インコーポレイテッド | Methods and compositions for increasing the lifetime of cell cultures and the yield of derived proteins |
KR102427429B1 (en) * | 2013-03-15 | 2022-08-01 | 인3바이오 리미티드 | Self-assembling synthetic proteins |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4504469A (en) * | 1982-12-21 | 1985-03-12 | Ferring Ab | Vasotocin derivatives |
US4780313A (en) * | 1985-12-24 | 1988-10-25 | Takeda Chemical Industries, Ltd. | Method of stimulating the immune system with a mixture of substances having IL-2 activity and muramyldipeptide |
US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
US5723441A (en) * | 1993-11-15 | 1998-03-03 | Celtrix Pharmaceuticals, Inc. | Method of treating renal disease by administering IGF-I and IGFBP-3 |
US5759996A (en) * | 1994-04-13 | 1998-06-02 | La Jolla Cancer Research Center | Peptides useful for altering αv β3 -mediated binding |
US5877148A (en) * | 1994-08-05 | 1999-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of cancer with human chorionic gonadotropin |
US6008195A (en) * | 1996-02-16 | 1999-12-28 | The Regents Of University Of California | Antimicrobial peptides and methods of use |
US6274335B1 (en) * | 1982-05-05 | 2001-08-14 | Genentech, Inc. | Method of treatment using recombinant human tissue plasminogen activator |
US6306648B1 (en) * | 1996-06-03 | 2001-10-23 | St. Jude Children's Research Hospital | Cyclin-C variants, and diagnostic and therapeutic uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60230858D1 (en) * | 2001-02-15 | 2009-03-05 | Centocor Inc | CHEMICALLY DEFINED MEDIUM FOR CULTIVATED MAMMALIAN CELLS |
-
2002
- 2002-12-11 AU AU2002362130A patent/AU2002362130A1/en not_active Abandoned
- 2002-12-11 WO PCT/US2002/039496 patent/WO2003052064A2/en active Application Filing
- 2002-12-11 JP JP2003552931A patent/JP2005512538A/en active Pending
- 2002-12-11 CA CA002470026A patent/CA2470026A1/en not_active Abandoned
- 2002-12-11 EP EP02797264A patent/EP1490481A4/en not_active Withdrawn
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274335B1 (en) * | 1982-05-05 | 2001-08-14 | Genentech, Inc. | Method of treatment using recombinant human tissue plasminogen activator |
US4504469A (en) * | 1982-12-21 | 1985-03-12 | Ferring Ab | Vasotocin derivatives |
US4780313A (en) * | 1985-12-24 | 1988-10-25 | Takeda Chemical Industries, Ltd. | Method of stimulating the immune system with a mixture of substances having IL-2 activity and muramyldipeptide |
US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
US5723441A (en) * | 1993-11-15 | 1998-03-03 | Celtrix Pharmaceuticals, Inc. | Method of treating renal disease by administering IGF-I and IGFBP-3 |
US5759996A (en) * | 1994-04-13 | 1998-06-02 | La Jolla Cancer Research Center | Peptides useful for altering αv β3 -mediated binding |
US5877148A (en) * | 1994-08-05 | 1999-03-02 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of cancer with human chorionic gonadotropin |
US6008195A (en) * | 1996-02-16 | 1999-12-28 | The Regents Of University Of California | Antimicrobial peptides and methods of use |
US6306648B1 (en) * | 1996-06-03 | 2001-10-23 | St. Jude Children's Research Hospital | Cyclin-C variants, and diagnostic and therapeutic uses thereof |
Non-Patent Citations (14)
Title |
---|
BIOTECHNOLOGY PROGRESS, vol. 16, no. 5, September 2000 (2000-09-01) - October 2000 (2000-10-01), pages 682 - 687 * |
BLOOD, vol. 96, no. 11, PART 2, 16 November 2000 (2000-11-16), pages 278B * |
CLINICAL THERAPEUTICS, vol. 21, no. 6, June 1999 (1999-06-01), pages 932 - 942 * |
CYTOTECHNOLOGY, vol. 22, no. 1-3, January 1996 (1996-01-01), pages 239 - 250 * |
DATABASE BIOSIS [online] BIOLOGICAL ABSTRACTS INC. (COLUMBUS, OH USA); HILL M.: "Adaptive state of mammalian cells and its nonseparability suggestive of a quantum system", XP002972612, accession no. STN Database accession no. 2001:152166 * |
DATABASE BIOSIS [online] BIOLOGICAL ABSTRACTS INC. (COLUMBUS, OH USA); LOUIS ET AL.: "Maintenance of clonotypic myeloma cells in serum-free media", XP002972615, accession no. STN Database accession no. 2001:311437 * |
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (BETHESDA, MD, USA); FAULDS ET AL.: "Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease", XP002972617, accession no. STN Database accession no. 95094637 * |
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (BETHESDA, MD, USA); MOUSER ET AL.: "Infliximab: a novel chimeric monoclonal antibody for the treatment of Crohn's disease", XP002972616, accession no. STN Database accession no. 1999367230 * |
DATABASE SCISEARCH [online] THOMSON ISI (COLUMBUS, OH, USA); GORFIEN ET AL.: "Growth of NSO cells in protein-free, chemically defined medium", XP002972614, accession no. STN Database accession no. 2000:780843 * |
DATABASE SCISEARCH [online] THOMSON ISI (COLUMBUS, OH, USA); ZHOU ET AL.: "Large scale production of recombinant mouse and rat growth hormone by fed-batch GS-NS0 cell cultures", XP002972618, accession no. STN Database accession no. 97:138896 * |
DRUGS, vol. 48, no. 4, October 1994 (1994-10-01), pages 583 - 598 * |
FRESHNEY R. IAN, 1994, WILEY-LISS, NEW YORK, article "Culture of animal cells", pages: 92 - 93, XP002972613 * |
SCRIPTA MEDICA (BRNO), vol. 73, no. 4, 2000, pages 211 - 222 * |
See also references of EP1490481A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP1490481A4 (en) | 2005-12-07 |
WO2003052064A2 (en) | 2003-06-26 |
EP1490481A2 (en) | 2004-12-29 |
CA2470026A1 (en) | 2003-06-26 |
JP2005512538A (en) | 2005-05-12 |
AU2002362130A1 (en) | 2003-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1360314A4 (en) | Chemically defined medium for cultured mammalian cells | |
WO2005116073A3 (en) | Pdx1 expressing endoderm | |
EP3486314A3 (en) | Placental stem cell populations | |
WO2007051038A3 (en) | Pdx1-expressing dorsal and ventral foregut endoderm | |
WO2005063971A3 (en) | Definitive endoderm | |
UA92157C2 (en) | Process for production of growth hormone | |
SG151259A1 (en) | Cardiomyocyte production | |
WO2006029198A3 (en) | Culturing human embryonic stem cells | |
WO2007070315A3 (en) | Improved production of glycoproteins using manganese | |
WO2005003320A3 (en) | Neuronal differentiation of stem cells | |
GB2432846A (en) | Medium and culture of embryonic stem cells | |
WO2004055155A3 (en) | Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same | |
AU1720400A (en) | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices | |
WO2007044418A3 (en) | Cell culture media, kits and methods of use | |
WO2006127809A3 (en) | Methods for expansion and analysis of cultured hematopoietic stem cells | |
WO2001021760A3 (en) | Cell culture spinner flasks | |
AU2019268061A1 (en) | Placental stem cell populations | |
WO2006004728A3 (en) | Cell culture medium comprising transition metals or trace elements | |
AU2002336930A1 (en) | Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture | |
EP2377922A3 (en) | PDX1 expressing endoderm | |
WO2003052064A3 (en) | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media | |
WO2003051720A3 (en) | A myeloma cell line useful for manufacturing recombinant proteins in chemically defined media | |
WO2004053080A3 (en) | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media | |
WO2004003217A8 (en) | Glutathione production | |
WO2003100010A3 (en) | Cytokine-free growth and maintenance of progenitor cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002362130 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2470026 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003552931 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002797264 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002797264 Country of ref document: EP |